WHO Classification of Tumours Online presents the authoritative content of the renowned classification series in a convenient digital format. Now combining the fourteen most recent volumes of the series in a searchable format, with high quality images and whole slide images.
WHO Classification of Tumours Online is indispensable for pathologists and cancer specialists worldwide. New volumes will be added regularly, ensuring immediate access to the latest content.
Don't have an account? Subscribe
The WHO Reporting Systems for Cytopathology are a joint project of the International Academy of Cytology, and the International Agency for Research on Cancer, a specialized agency of the World Health Organization. This series is a synthesis of the published evidence and the practice of cytopathology, linked to the WHO Classification of Tumours, now in their 5th Edition. Cytopathology reporting uses a hierarchial system of diagnostic categories. These categories are linked to diagnostic management recommendations to improve communication with clinicians and assist patient care.
The concise and authoritative information that characterizes the print books, enhanced with whole slide images and zoom
Compiled and reviewed by an international editorial board
Digital pathology enhancements
See images in their full detail
The 13 most recent volumes from the 4th and 5th editions
New volumes are continually added
Pay once a year and have access 24/7
The WHO Classification of Tumours series you've been relying on for years are now available as a convenient online subscription, including new features such as whole slide images, favourite sections and personal notes.
Subscribe
The world owes much to Richard Scolyer, a world expert on melanoma who contributed enormously to our understanding of this skin cancer. The WHO Classification of Tumours forms the basis for cancer diagnosis worldwide, and his contributions to this were truly international. His reaction to his brain tumour diagnosis was typical: he saw it as a major challenge and an opportunity to advance the science. That he did so publicly ensured that his response to his illness had the greatest impact. In doing so he inspired many who suffer from cancer, many cancer researchers and people around the world.
Richard was a wonderful mentor, a gifted speaker, and a tireless researcher. He worked brilliantly with other experts to revolutionise the way in which skin cancers are now diagnosed and treated. His wise council will be greatly missed, but his work lives on in the lives of those he touched through work, friendship, and inspiration.
WHO Classification of Tumours Team